Norsk Titanium Completes Full Scale Article Testing with GA-ASI
Norsk Titanium US Inc. (OSL: NTI, OTCQB: NORSF), a global leader in metal 3D printing through its Rapid Plasma Deposition® (RPD®) technology, announces successful component level testing with General Atomics Aeronautical Systems, Inc. (GA-ASI).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220426005084/en/
Finished GA-ASI Component & Norsk Titanium RPD® Form (Photo: Business Wire)
Started in 2021, the test program explored the application of Norsk Titanium’s RPD® technology in significant structural applications for GA-ASI products. The preliminary test results for the selected landing gear component indicated promising performance.
This effort was performed as part of Norsk Titanium’s expansion into the defense market with Norsk Titanium US producing the test component using their patented RPD® additive technology. GA-ASI additive and structural engineering teams conducted inspection and functional load testing as well as material testing. Testing was conducted in support of the GA-ASI mission to enable and accelerate additive manufacturing technology integration into their design & manufacturing operations, processes, and products maximizing the buy-to-fly ratio benefits for GA-ASI and their customers.
“We would like to thank GA-ASI for their support of our technology and the additive industry in general,” said Nicholas Mayer, Norsk Titanium Vice President, Commercial. “We believe there is a good fit for our technology in GA-ASI applications that traditionally call for long lead time forgings. Our team is ready to support GA-ASI as they continue their qualification process and further develop their DED additive applications.”
ABOUT NORSK TITANIUM
Norsk Titanium is a global leader in metal 3D printing, innovating the future of metal manufacturing by enabling a paradigm shift to a clean and sustainable manufacturing process. With its proprietary Rapid Plasma Deposition® (RPD®) technology and 700 MT of production capacity, Norsk Titanium offers cost-efficient 3D printing of value-added metal parts to a large addressable market. The RPD® technology uses significantly less raw material, energy, and time than traditional energy-intensive forming methods, presenting customers with an opportunity to better manage input costs, logistics, and environmental impact. RPD® printed parts are already flying on commercial aircraft, and Norsk Titanium has gained significant traction with large defense and industrial customers.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220426005084/en/
Contact information
Lauren Quesada, Griffin Communications Group
Lauren@griffincg.com;+1 281-744-7938
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Valeo Foods Group Recognised for Sustainability Leadership with EcoVadis Platinum Medal20.10.2025 10:00:00 EEST | Press release
Valeo Foods Group, one of Europe's leading producers of quality sweets, treats and snacks has been awarded a Platinum Medal, the highest recognition level, in the EcoVadis sustainability assessment. Valeo Foods now ranks among the top one percent of companies evaluated. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251020547491/en/ Valeo Foods Group recognised for sustainability leadership with EcoVadis Platinum Medal. Ronald Kers, Valeo Foods Group CEO said “Achieving EcoVadis Platinum rating is a proud moment for our business. It reflects the dedication of our people and our determination to integrate sustainability into everything we do – from how we source and produce, to how we support communities and protect the planet.” Dr Grainne O’Halloran, Head of Sustainability at Valeo Foods added: “We are incredibly proud to have achieved EcoVadis Platinum Medal this year. Our increased score reflects our ongoing commitment to
Lazard Appoints Edouard Panié as Managing Director and Co-Head of European Financial Sponsors Coverage20.10.2025 09:00:00 EEST | Press release
Lazard, Inc. (NYSE: LAZ) today announced the appointment of Edouard Panié as Managing Director and Co-Head of the European Financial Sponsors Coverage. He will report to Klaus H. Hessberger, Global Co-Head and Head of Europe for Lazard’s Financial Sponsors Group, to further strengthen the firm’s presence and partnerships with financial sponsors across the region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251019307537/en/ Edouard Panié Mr. Panié joins from Goldman Sachs, where he was a Managing Director for nearly two decades, advising on more than 60 landmark M&A, debt, and equity transactions for leading alternative asset managers in private equity, growth equity, and infrastructure, as well as entrepreneurs, families, and corporates. “Private capital is playing an increasingly pivotal role in shaping industries and driving growth. Edouard’s extensive experience and relationships will strengthen Lazard’s ability to pro
Lone Star Announces Sale of Xella to Holcim20.10.2025 07:40:00 EEST | Press release
Lone Star Funds (“Lone Star”) today announced the signing by an affiliate of Lone Star Fund X, LP of a binding agreement to sell Xella Group (“Xella”), a leading provider of walling solutions, to Holcim, the leading partner for sustainable construction. The transaction values Xella at approximately €1.85 billion. Headquartered in Duisburg, Germany, Xella is a European provider of efficient and sustainable walling solutions for the entire house shell, operating brands such as Ytong, Silka, Hebel and Multipor. The company employs more than 4,000 team members. In partnership with Lone Star, Xella has taken significant strides in recent years to optimize its offering by strategically focusing the business on walling solutions, while also enhancing its commercial and digital capabilities. Under Lone Star’s stewardship, Xella has also continued to progress its sustainability initiatives. Today, the business stands as a market leader in its sector with a strong reputation for a people-first c
Worldwide First: Biedermann Motech Further Expands its MOSS!MODULARITY Platform and Announces Introduction of Multiple New Products20.10.2025 07:00:00 EEST | Press release
Biedermann Motech, the prominent innovator in next generation spinal and extremity implant systems and procedural solutions, today announced the market introduction of several additions to its MOSS!MODULARITY™ platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251019799867/en/ MOSS!MODULARITY Injection Screw MOSS!MODULARITY encompasses a broad range of products and technologies for spinal surgery based around the concept of providing an advanced modular workflow for posterior stabilization and deformity correction. The modular workflow allows surgeons to place the headless bone screw shafts as a first step, without the tulip heads attached, and offers several advantages over working with traditional pre-assembled pedicle screws, e.g.: Improved visualisation and access to the surgical working space; Precise decompression, decortication and osteotomies without any interference with polyaxial tulip heads; Increased surgic
Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific Antibody in Advanced Colorectal Cancer and KRAS G12D Inhibitor in Advanced Pancreatic Ductal Adenocarcinoma19.10.2025 20:30:00 EEST | Press release
Incyte (Nasdaq:INCY) announced the first clinical data evaluating its TGFβR2×PD-1 bispecific antibody (INCA33890) for patients with microsatellite stable (MSS) colorectal cancer; and its potent, selective and orally bioavailable KRAS G12D inhibitor (INCB161734) for patients with KRAS G12D mutations, specifically pancreatic ductal adenocarcinoma (PDAC). The data were featured in two oral sessions (Investigational immunotherapy; Abstract #1522MO and Developmental therapeutics; Abstract #916O, respectively) at the European Society of Medical Oncology (ESMO) Congress 2025. “The proof-of-concept data highlight the potential of INCA33890 and INCB161734 to address significant medical needs in patients with advanced solid tumors, including MSS colorectal cancer and PDAC,” said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. “These results, including the favorable safety profiles as monotherapies, support continued clinical development. We look forward to explori
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom